Table 1 Baseline characteristics
From: Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation
Non sedated n = 38 (48%) | Sedated n = 41(51%) | p value | |
|---|---|---|---|
Gender (female) | 10 (26%) | 20 (49%) | 0.026 |
Height | 173 (± 8) | 170 (± 8) | 0.056 |
Weight | 85 (± 17) | 81 (± 22) | Ns |
BMI | 28 (± 5) | 28 (± 8) | Ns |
Age | 72 (± 10) | 70 (± 11) | Ns |
APACHE II | 28 (± 7) | 28 (± 8) | Ns |
SAPS II | 47 (± 17) | 51 (± 13) | Ns |
SOFA day 1 | 8 (± 4) | 7 (± 4) | Ns |
SOFA day 2 | 7 (± 4) | 7 (± 5) | Ns |
SOFA day 3 | 6 (± 3) | 7 (± 4) | Ns |
SOFA day 4 | 6 (± 3) | 7 (± 4) | Ns |
Respiratory insufficiency | 17 | 17 | |
Sepsis | 11 | 12 | |
Quinckes edema | 1 | 0 | |
Influenza | 0 | 1 | |
Pneumonia | 3 | 6 | |
COPD | 3 | 0 | |
Epiglottitis | 0 | 1 | |
Rhabdomyolysis | 1 | 0 |